AIM: To study the effect of Danggui Shaoyao Powder combined with trabeculectomy and bevacizumab on neovascular glaucoma

METHODS:Neovascular glaucoma patients were enrolled from January 2011 to February 2014 in our hospital, according to the different methods of treatment were divided into observation group given traditional Chinese medicine and Western medicine combined with trabeculectomy, and control group received Western medicine combined with trabeculectomy. Visual acuity, intraocular pressure, retinal thickness were compared.

RESULTS: Visual acuity level: 1wk; 6, 12mo after treatment, visual acuity in observation group were significantly higher than that in control group(0.41±0.07 vs 0.27±0.04, 0.52±0.08 vs 0.38±0.06, 0.72±0.14 vs 0.54±0.08); Intraocular pressure: 1wk; 6, 12mo after treatment, intraocular pressure in observation group were significantly lower than that in control group(15.11±3.22 vs 22.32±5.34, 18.64±5.08 vs 26.67±6.22, 17.18±3.76 vs 22.42±4.32)mmHg; Retinal nerve fiber layer thickness: 12mo after treatment, nerve fiber layer thickness in observation group was significantly higher than that in control group(90.41±10.52 vs 78.64±8.24, 88.38±12.12 vs 72.37±8.82, 73.21±8.46 vs 60.25±7.23, 75.35±8.13 vs 62.63±7.29)μm.

CONCLUSION:Danggui Shaoyao Powder combined with trabeculectomy and bevacizumab on neovascular glaucoma can promote visual acuity recovery, control intraocular pressure, and improve the retinal nerve fiber layer thickness.